Meta-analysis: rectal indomethacin for the prevention of post-ERCP pancreatitis
Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease
Review article: the association between nodular regenerative hyperplasia, inflammatory bowel disease and thiopurine therapy
Review article: coffee consumption, the metabolic syndrome and non-alcoholic fatty liver disease
Randomised clinical trial: MRCP-first vs. ERCP-first approach in patients with suspected biliary obstruction due to bile duct stones
Randomised clinical trial: sodium alginate oral suspension is non-inferior to omeprazole in the treatment of patients with non-erosive gastroesophageal disease
The impact of chronic hepatitis C on resource utilisation and in-patient mortality for Medicare beneficiaries between 2005 and 2010
Telaprevir-based triple therapy for chronic hepatitis C patients with advanced fibrosis: a prospective clinical study
Novel serological neo-epitope markers of extracellular matrix proteins for the detection of portal hypertension
Factors associated with thiopurine non-adherence in patients with inflammatory bowel disease
The management of iron deficiency in inflammatory bowel disease – an online tool developed by the RAND/UCLA appropriateness method
Risk factors of gastrointestinal bleeding in clopidogrel users: a nationwide population-based study
Twice-daily dosing of esomeprazole effectively inhibits acid secretion in CYP2C19 rapid metabolisers compared with twice-daily omeprazole, rabeprazole or lansoprazole
Commentary: 5-ASA switches in IBD, adherence and flares
Commentary: 5-ASA switches in IBD, adherence and flares – authors' reply
Commentary: biopsy to diagnose GERD – better, but not yet a stand-alone test
Commentary: biopsy to diagnose GERD – better, but not yet a stand-alone test; authors' reply
Commentary: synbiotics and gut microbiota in older people – a microbial guide to healthy ageing
Letter: treatment of autoimmune acute liver failure – beyond consensus guidelines
Letter: treatment of autoimmune acute liver failure – beyond consensus guidelines; author's reply